These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Colony-forming capacity of the bone marrow and blood cells in vitro in different forms of acute leukemia]. Zabelina TS, Afanas'ev BV, Zaritskiĭ AIu, Postriganeva TN, Saĭdali MA. Ter Arkh; 1977; 49(8):53-9. PubMed ID: 929395 [No Abstract] [Full Text] [Related]
31. [Heterogeneity of leukemia cell phenotype. I. Variants of hetero- phenotype in relation to myeloid and erythrocytic markers of leukemic cells in acute leukemia and blast crisis of chronic myeloproliferative disorders]. Kemnitz J, Helmke M, Frend M, Bür T, Dominis M, Horitz H. Gematol Transfuziol; 1990 Aug; 35(8):9-14. PubMed ID: 2253865 [No Abstract] [Full Text] [Related]
32. Treatment of murine myeloid leukemia by aclacinomycin-A based on the dynamics of leukemic colony forming unit and normal hematopoietic stem cells. Nara N. Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1324-32. PubMed ID: 6963084 [No Abstract] [Full Text] [Related]
33. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation. Murohashi I, Endho K, Nishida S, Yoshida S, Jinnai I, Bessho M, Hirashima K. Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418 [Abstract] [Full Text] [Related]